0001209191-23-059368.txt : 20231220 0001209191-23-059368.hdr.sgml : 20231220 20231220165828 ACCESSION NUMBER: 0001209191-23-059368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231218 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Protopapas Anna CENTRAL INDEX KEY: 0001347582 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 231501986 MAIL ADDRESS: STREET 1: MILLENNIUM PHARMACEUTICALS, INC. STREET 2: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-18 0 0001861560 Nuvalent, Inc. NUVL 0001347582 Protopapas Anna C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 0 Class A Common Stock 2023-12-18 4 M 0 5000 9.36 A 5000 D Class A Common Stock 2023-12-18 4 S 0 5000 75.67 D 0 D Stock Option (Right to Buy) 9.36 2023-12-18 4 M 0 5000 0.00 D 2032-06-16 Class A Common Stock 5000 15000 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $75.76, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. This option is fully vested and exercisable. /s/ Deborah A. Miller, attorney-in-fact 2023-12-20